-transparent.png){kind=logo}
In the therapeutically important range (100-200 micrograms/ml), suramin was found to increase the phagocytic activity of human monocytes (measured by the uptake of Saccharomyces cerevisiae and sensitized sheep red blood cells) in vitro. Suramin itself was a chemotactic signal for monocytes and increased the chemiluminescence of neutrophil granulocytes. Suramin seems to act via the ATP-binding P2 receptors of human phagocytes.
Related Publications
S Sipka, and
K Dankó, and
P Nagy, and
V Taskov, and
L Dénes, and
L Czirják, and
G Szegedi
March 2008,
International journal of antimicrobial agents,
S Sipka, and
K Dankó, and
P Nagy, and
V Taskov, and
L Dénes, and
L Czirják, and
G Szegedi
February 2000,
Anti-cancer drugs,
S Sipka, and
K Dankó, and
P Nagy, and
V Taskov, and
L Dénes, and
L Czirják, and
G Szegedi
April 1992,
Journal of the National Cancer Institute,
S Sipka, and
K Dankó, and
P Nagy, and
V Taskov, and
L Dénes, and
L Czirják, and
G Szegedi
October 1991,
Metabolism: clinical and experimental,
S Sipka, and
K Dankó, and
P Nagy, and
V Taskov, and
L Dénes, and
L Czirják, and
G Szegedi
December 1992,
Acta medica Okayama,
S Sipka, and
K Dankó, and
P Nagy, and
V Taskov, and
L Dénes, and
L Czirják, and
G Szegedi
May 1983,
The Journal of pharmacology and experimental therapeutics,
S Sipka, and
K Dankó, and
P Nagy, and
V Taskov, and
L Dénes, and
L Czirják, and
G Szegedi
September 1976,
Tropenmedizin und Parasitologie,
S Sipka, and
K Dankó, and
P Nagy, and
V Taskov, and
L Dénes, and
L Czirják, and
G Szegedi
January 1993,
European journal of cancer (Oxford, England : 1990),
S Sipka, and
K Dankó, and
P Nagy, and
V Taskov, and
L Dénes, and
L Czirják, and
G Szegedi
January 2007,
Pharmacology,
S Sipka, and
K Dankó, and
P Nagy, and
V Taskov, and
L Dénes, and
L Czirják, and
G Szegedi
February 1978,
Experimental cell research,
